Cargando…

Correction: A-Methylacyl-CoA Racemase (AMACR) and Prostate-Cancer Risk: A Meta-Analysis of 4,385 Participants

Detalles Bibliográficos
Autores principales:	Jiang, Ning, Zhu, Shimiao, Chen, Jing, Niu, Yuanjie, Zhou, Liqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730224/ https://www.ncbi.nlm.nih.gov/pubmed/29220849 http://dx.doi.org/10.1371/annotation/677fdf34-651e-4dc8-a0be-d0d633237a85

Ejemplares similares

A-Methylacyl-CoA Racemase (AMACR) and Prostate-Cancer Risk: A Meta-Analysis of 4,385 Participants
por: Jiang, Ning, et al.
Publicado: (2013)

Correction: Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer
por: Shapovalova, Mariya, et al.
Publicado: (2019)

Alpha-Methylacyl-CoA Racemase (AMACR), a Potential New Biomarker for Glioblastoma
por: Lee, Hyunji, et al.
Publicado: (2020)

α-methylacyl-CoA racemase (AMACR) expression in chordomas differentiates them from chondrosarcomas
por: Aviel-Ronen, Sarit, et al.
Publicado: (2016)

Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer
por: Shapovalova, Mariya, et al.
Publicado: (2018)

α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC
por: Xu, Bo, et al.
Publicado: (2014)

Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor
por: Lin, Po-Yuan, et al.
Publicado: (2012)

Diagnostic utility of a-methylacyl COA racemase in prostate cancer of the Iranian population
por: Taheri, Diana, et al.
Publicado: (2021)

Diagnostic Value of Cytokeratin 34 beta E12 (Ck34βE12) and α-Methylacyl-CoA racemase (AMACR) Immunohistochemical Expression in Prostatic Lesions
por: Hasan, Ikram A., et al.
Publicado: (2020)

Asymptomatic retinal dysfunction in alpha-methylacyl-CoA racemase deficiency
por: Alsalamah, Abrar K., et al.
Publicado: (2021)

Increased expression of α-methylacyl-coenzyme A racemase (AMACR; p504s) and p16 in distal hyperplastic polyps
por: Dayi, Nimet, et al.
Publicado: (2013)

The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer
por: Yang, Daijun, et al.
Publicado: (2020)

Expression and Characterization of α-Methylacyl CoA Racemase from Anisakis simplex Larvae
por: Kim, Bong Jin, et al.
Publicado: (2012)

Pseudohyperplastic variant of adenocarcinoma as a component of α-methyl–CoA-racemase (AMACR negative) carcinosarcoma of the prostate
por: Dudani, Sharmila, et al.
Publicado: (2015)

Diagnostic utility of α-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer
por: Kumaresan, K, et al.
Publicado: (2010)

Genetic Variations of α-Methylacyl-CoA Racemase Are Associated with Sporadic Prostate Cancer Risk in Ethnically Homogenous Koreans
por: Lee, Sang-Jin, et al.
Publicado: (2013)

Autoantibody Positivity in Two Bahraini Siblings With a Novel Alpha-Methylacyl-CoA Racemase Mutation
por: Isa, Hasan M, et al.
Publicado: (2023)

MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing
por: Haugarvoll, Kristoffer, et al.
Publicado: (2013)

Gastric neuroendocrine carcinoma with positive staining for prostate cancer markers including prostate-specific antigen and alpha-methylacyl-CoA racemase
por: Hakozaki, Yuji, et al.
Publicado: (2018)

Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based α-Methylacyl-CoA Racemase Score: A Single-Center Experience
por: Ji, Jin, et al.
Publicado: (2019)

Diagnostic Accuracy of Alpha-Methylacyl-CoA Racemase Immunohistochemical Expression for the Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas
por: Nili, Fatemeh, et al.
Publicado: (2023)

Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma
por: Li, Wei, et al.
Publicado: (2008)

Alpha-methylacyl-coenzyme A racemase expression in neuroendocrine neoplasms of the stomach
por: Annenkov, Alexey, et al.
Publicado: (2012)

Alpha-Methylacyl-Coenzyme A Racemase-Expressing Urachal Adenocarcinoma of the Abdominal Wall
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer
por: Honma, Ichiya, et al.
Publicado: (2009)

Suppression of α-methylacyl-coenzyme A racemase by miR200c inhibits prostate adenocarcinoma cell proliferation and migration
por: Xie, Hanbing, et al.
Publicado: (2020)

Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study
por: Samir Sayed, Rasha Mohamed, et al.
Publicado: (2023)

Combined α-methylacyl-CoA racemase inhibition and docetaxel treatment reduce cell proliferation and decrease expression of heat shock protein 27 in androgen receptor-variant-7–positive prostate cancer cells
por: Yoshizawa, Atsuhiko, et al.
Publicado: (2021)

The expressions of AMACR and iNOS in prostate adenocarcinomas
por: Ozgur, Tumay, et al.
Publicado: (2013)

Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate
por: Alinezhad, Saeid, et al.
Publicado: (2016)

Oncogenic Activity of Solute Carrier Family 45 Member 2 and Alpha‐Methylacyl‐Coenzyme A Racemase Gene Fusion Is Mediated by Mitogen‐Activated Protein Kinase
por: Zuo, Ze‐Hua, et al.
Publicado: (2021)

Correction: Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer
por: Zhu, Shimiao, et al.
Publicado: (2019)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

4385 The Pain and Social Experiences Project: Understanding the role of interpersonal trauma in pain
por: Pierce, Jennifer, et al.
Publicado: (2020)

Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
por: Chen, Xuanrong, et al.
Publicado: (2023)

Current Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases
por: Kong, Gyeyeong, et al.
Publicado: (2020)

Corrigendum: Current Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases
por: Kong, Gyeyeong, et al.
Publicado: (2021)

AB125. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality
por: Niu, Yuanjie, et al.
Publicado: (2015)

AB187. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality
por: Niu, Yuanjie, et al.
Publicado: (2016)

Correction: Evaluating prognosis by CK7 differentiating renal cell carcinomas from oncocytomas can be used as a promising tool for optimizing diagnosis strategies
por: Ma, Fuling, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jhld353bqcfbib5aihavtj0j8v